According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Aardvark Therapeutics are Chief Executive Officer Tien-Li Lee (1.54Mn shares), Chief Financial Officer Nelson Sun (105.48K shares), Chief Operating Officer Bryan Jones (1.25K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Venture Fund Vi Pte Ltd Vickers | 2,050,902 | 19 Feb, 2025 | |
| Tien-Li Lee | Chief Executive Officer | 1,551,613 | 12 Dec, 2025 |
| Asset Management, Lp Cormorant | 987,689 | 19 Feb, 2025 | |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | 958,412 | 19 Feb, 2025 | |
| Jeffrey Chi | 133,364 | 19 Feb, 2025 | |
| Nelson Sun | Chief Financial Officer | 108,484 | 12 Dec, 2025 |
| Bryan Jones | Chief Operating Officer | 1,250 | 16 Oct, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Dec, 2025 | Tien-Li Lee | Common Stock | A | 7,000 | $14.48 | 1,551,613 | D | P |
| 11 Dec, 2025 | Nelson Sun | Common Stock | A | 3,000 | $14.40 | 108,484 | D | P |
| 15 Oct, 2025 | Bryan Jones | Common Stock | A | 1,250 | $4.24 | 1,250 | D | M |
| 15 Oct, 2025 | Tien-Li Lee | Common Stock | A | 1,229 | $4.24 | 1,544,613 | D | M |
| 15 Sep, 2025 | Tien-Li Lee | Common Stock | A | 6,500 | $9.51 | 1,539,884 | D | P |
| 15 Sep, 2025 | Tien-Li Lee | Common Stock | A | 3,500 | $9.94 | 1,543,384 | D | P |
| 10 Sep, 2025 | Tien-Li Lee | Common Stock | A | 9,000 | $7.91 | 1,522,384 | D | P |
| 11 Sep, 2025 | Tien-Li Lee | Common Stock | A | 6,000 | $7.82 | 1,528,384 | D | P |
| 12 Sep, 2025 | Tien-Li Lee | Common Stock | A | 5,000 | $8.50 | 1,533,384 | D | P |
| 09 Sep, 2025 | Nelson Sun | Common Stock | A | 6,000 | $8.07 | 105,484 | D | P |
| 28 Aug, 2025 | Tien-Li Lee | Common Stock | A | 17,209 | $4.24 | 1,513,384 | D | M |
| 14 Feb, 2025 | Asset Management, Lp Cormorant | Common Stock | A | 800,189 | - | 800,189 | I | C |
| 14 Feb, 2025 | Nelson Sun | Common Stock | A | 7,001 | - | 89,484 | D | C |
| 14 Feb, 2025 | Tien-Li Lee | Common Stock | A | 41,303 | - | 1,479,633 | D | C |
| 14 Feb, 2025 | Venture Fund Vi Pte Ltd Vickers | Common Stock | A | 1,637,411 | - | 1,637,411 | I | C |
| 14 Feb, 2025 | Jeffrey Chi | Common Stock | A | 133,364 | - | 133,364 | I | C |
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | Common Stock | A | 2,333,887 | - | 2,333,887 | I | C |
| 14 Feb, 2025 | Asset Management, Lp Cormorant | - | - | 800,189 | I | |||
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | - | - | 333,412 | I | |||
| 14 Feb, 2025 | Venture Fund Vi Pte Ltd Vickers | Common Stock | A | 413,491 | - | 2,050,902 | I | C |